Filana Therapeutics, Inc.
FLNA
$1.42
-$0.01-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.33M | -12.54M | -10.81M | -44.22M | -23.40M |
| Total Depreciation and Amortization | 243.00K | 367.00K | 131.00K | 218.00K | 220.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.07M | 5.37M | 4.40M | 4.58M | 5.23M |
| Change in Net Operating Assets | -2.86M | -2.95M | 53.00K | 34.48M | 6.62M |
| Cash from Operations | -8.88M | -9.75M | -6.22M | -4.95M | -11.34M |
| Capital Expenditure | -- | -501.00K | -80.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -501.00K | -80.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 0.00 | 90.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -51.00K | -329.00K | -- | -- | -- |
| Cash from Financing | -51.00K | -329.00K | 0.00 | 0.00 | 90.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.93M | -10.58M | -6.30M | -4.95M | -11.25M |